EU Consumers Push Back on Big Pharma Bid to Relax Covid-19 Translation Rules
Drug manufacturers want EU regulators to pick one language to go on Covid-19 vaccine labels and instructions for all 27 Member States; EU consumer group says not so fast.
*New* Slator Pro Guide: Scaling an LSP Key Account — Growing Small Clients into Key Accounts
pharmaceutical translation
Translation Services and the Race for a Coronavirus Vaccine
With hundreds of coronavirus clinical studies underway, what role does the language industry play in facilitating the search for a vaccine? Where does linguistic validation fit in?
Honyaku Center Posts Decline in Translation Revenues for H1 FY 2020
Honyaku Center reports decline in all sectors of core Translation Business, except for Patents. Banks on “active use” of machine translation to grow.
Shares in Japan’s Largest LSP Plummet on Declining Q1 FY20 Revenues
Shares in Japanese language service provider Honyaku Center plummet on declining Q1 2020 sales. Its largest unit, Translation, retreated across all sectors bar Patents.
Slator 2019 Life Sciences Translation Report
Slator’s 2019 report on the clinical life sciences translation industry, analysis of the competitive landscape and actionable insights from major buyers of pharmaceutical translation.
Why Linguistic Validation Requires Not Just Conceptual but Cultural Equivalence
Adelina Lear of contract research organization ICON plc spoke at SlatorCon London on the role of language services and the linguistic validation workflow in clinical trials.
Your information will not be shared with third parties. No Spam.